A MALT1 inhibitor suppresses human myeloid DC, effector T-cell and B-cell responses and retains Th1/regulatory T-cell homeostasis
Céline Dumont(Vrije Universiteit Brussel), Outi Vaarala(Orion Corporation (United Kingdom))
Cited by 21
Related Papers
The Dynamics of the Human Infant Gut Microbiome in Development and in Progression toward Type 1 Diabetes
|Cell Host & Microbe|2015|1.2k
The case for elimination of cow's milk in early infancy in the prevention of type 1 diabetes: The finnish experience
|Diabetes/Metabolism Reviews|1993|76
Maturation of Gut Microbiota and Circulating Regulatory T Cells and Development of IgE Sensitization in Early Life
|Frontiers in Immunology|2019|60
The Dynamics of the Human Infant Gut Microbiome in Development and in Progression toward Type 1 Diabetes
|Cell Host & Microbe|2016|41